<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/tarver-takes-home-health-case-to-aami-RMR36QJFGFA63JOXM7KHIB5PCU/</loc><lastmod>2026-04-18T00:42:53.083Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:42:53.083Z</news:publication_date><news:title><![CDATA[Tarver Takes Home Health Case To AAMI]]></news:title></news:news><image:image><image:loc>https://insights.citeline.com/resizer/QrSeNjd7P0Ypp5dtAOhR9jWMNUw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HLNXW6KNO5C27IFUZ5B23D5CWY.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/companies/pentixapharm-holding-ag</loc><lastmod>2026-04-18T00:13:53.486Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:53.486Z</news:publication_date><news:title><![CDATA[Pentixapharm Holding AG]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/guangzhou-innogen-pharmaceutical-group</loc><lastmod>2026-04-18T00:13:51.372Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:51.372Z</news:publication_date><news:title><![CDATA[Guangzhou Innogen Pharmaceutical Group]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/shanxi-yuanyang-pharmaceutical-technology-co-ltd</loc><lastmod>2026-04-18T00:13:49.457Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:49.457Z</news:publication_date><news:title><![CDATA[Shanxi Yuanyang Pharmaceutical Technology Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/argus-cognitive-inc</loc><lastmod>2026-04-18T00:13:45.378Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:45.378Z</news:publication_date><news:title><![CDATA[Argus Cognitive, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/cells-first-biotechnology-beijing-co-ltd</loc><lastmod>2026-04-18T00:13:41.325Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:41.325Z</news:publication_date><news:title><![CDATA[Cells First Biotechnology (Beijing) Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/orthorebirth-co-ltd</loc><lastmod>2026-04-18T00:13:37.202Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:37.202Z</news:publication_date><news:title><![CDATA[ORTHOREBIRTH Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/abrexa-pharmaceuticals-inc</loc><lastmod>2026-04-18T00:13:33.405Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:33.405Z</news:publication_date><news:title><![CDATA[Abrexa Pharmaceuticals, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/chinese-academy-of-sciences</loc><lastmod>2026-04-18T00:13:29.271Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:29.271Z</news:publication_date><news:title><![CDATA[Chinese Academy of Sciences]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/insight-lifetech</loc><lastmod>2026-04-18T00:13:25.25Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:25.25Z</news:publication_date><news:title><![CDATA[Insight Lifetech]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/t-e-pharma-holding-company</loc><lastmod>2026-04-18T00:13:21.209Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:21.209Z</news:publication_date><news:title><![CDATA[T-E Pharma Holding Company]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/lin-gang-laboratory</loc><lastmod>2026-04-18T00:13:09.453Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:09.453Z</news:publication_date><news:title><![CDATA[Lin Gang Laboratory]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/waters-corporation</loc><lastmod>2026-04-18T00:13:07.254Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:07.254Z</news:publication_date><news:title><![CDATA[Waters Corporation]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/sharp</loc><lastmod>2026-04-18T00:13:05.286Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:05.286Z</news:publication_date><news:title><![CDATA[Sharp]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/owlet-inc</loc><lastmod>2026-04-18T00:13:03.19Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:03.19Z</news:publication_date><news:title><![CDATA[Owlet Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/minimed-inc</loc><lastmod>2026-04-18T00:13:01.084Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:13:01.084Z</news:publication_date><news:title><![CDATA[MiniMed Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/shanghai-affinity-biomedical-technology-co-ltd</loc><lastmod>2026-04-18T00:12:59.209Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:59.209Z</news:publication_date><news:title><![CDATA[Shanghai Affinity Biomedical Technology Co., Ltd]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/suzhou-maidetong-pharmaceutical-technology-co-ltd</loc><lastmod>2026-04-18T00:12:55.369Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:55.369Z</news:publication_date><news:title><![CDATA[Suzhou Maidetong Pharmaceutical Technology Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tetratherix</loc><lastmod>2026-04-18T00:12:50.944Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:50.944Z</news:publication_date><news:title><![CDATA[Tetratherix]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/organoid-sciences</loc><lastmod>2026-04-18T00:12:48.071Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:48.071Z</news:publication_date><news:title><![CDATA[Organoid Sciences]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/inflammatics-inc</loc><lastmod>2026-04-18T00:12:38.981Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:38.981Z</news:publication_date><news:title><![CDATA[Inflammatics Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/methode-electronics</loc><lastmod>2026-04-18T00:12:34.842Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:34.842Z</news:publication_date><news:title><![CDATA[Methode Electronics]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nagase-viita-co-ltd</loc><lastmod>2026-04-18T00:12:30.694Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:30.694Z</news:publication_date><news:title><![CDATA[Nagase Viita Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/optus-pharmaceutical-co-ltd</loc><lastmod>2026-04-18T00:12:26.769Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:26.769Z</news:publication_date><news:title><![CDATA[OPTUS Pharmaceutical Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/enliven-therapeutics-inc</loc><lastmod>2026-04-18T00:12:22.743Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:22.743Z</news:publication_date><news:title><![CDATA[Enliven Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/broncus-holding-corp</loc><lastmod>2026-04-18T00:12:16.586Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:16.586Z</news:publication_date><news:title><![CDATA[Broncus Holding Corp.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/oruka-therapeutics-inc</loc><lastmod>2026-04-18T00:12:12.58Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:12.58Z</news:publication_date><news:title><![CDATA[Oruka Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/aqilion-ab</loc><lastmod>2026-04-18T00:12:08.609Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:08.609Z</news:publication_date><news:title><![CDATA[Aqilion AB]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/quiapeg-pharmaceuticals-holding-ab</loc><lastmod>2026-04-18T00:12:04.623Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:04.623Z</news:publication_date><news:title><![CDATA[Quia Pharma AB]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/jiangsu-recbio-technology-co-ltd</loc><lastmod>2026-04-18T00:12:00.472Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:12:00.472Z</news:publication_date><news:title><![CDATA[Jiangsu Recbio Technology Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/canaquest-medical-corp</loc><lastmod>2026-04-18T00:11:56.636Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:56.636Z</news:publication_date><news:title><![CDATA[CanaQuest Medical Corp]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/prokidney-lp</loc><lastmod>2026-04-18T00:11:48.367Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:48.367Z</news:publication_date><news:title><![CDATA[ProKidney LP]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/coya-therapeutics-inc</loc><lastmod>2026-04-18T00:11:44.472Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:44.472Z</news:publication_date><news:title><![CDATA[Coya Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/curacle-co-ltd</loc><lastmod>2026-04-18T00:11:42.384Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:42.384Z</news:publication_date><news:title><![CDATA[Curacle Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/climb-bio-inc</loc><lastmod>2026-04-18T00:11:36.362Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:36.362Z</news:publication_date><news:title><![CDATA[Climb Bio, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/microport-cardioflow-medtech-corp</loc><lastmod>2026-04-18T00:11:32.556Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:32.556Z</news:publication_date><news:title><![CDATA[MicroPort CardioFlow Medtech Corp.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/talis-biomedical-corp</loc><lastmod>2026-04-18T00:11:28.307Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:28.307Z</news:publication_date><news:title><![CDATA[Talis Biomedical Corp.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/wuhan-yzy-biopharma-co-ltd</loc><lastmod>2026-04-18T00:11:24.256Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:24.256Z</news:publication_date><news:title><![CDATA[Wuhan YZY Biopharma Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nyrada-inc</loc><lastmod>2026-04-18T00:11:20.389Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:20.389Z</news:publication_date><news:title><![CDATA[Nyrada, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/curative-biotechnology-inc</loc><lastmod>2026-04-18T00:11:18.225Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:18.225Z</news:publication_date><news:title><![CDATA[Curative Biotechnology Inc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/immunotech-biopharm-ltd</loc><lastmod>2026-04-18T00:11:14.178Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:14.178Z</news:publication_date><news:title><![CDATA[Immunotech Biopharm Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/kanaph-therapeutics-inc</loc><lastmod>2026-04-18T00:11:10.199Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:10.199Z</news:publication_date><news:title><![CDATA[Kanaph Therapeutics Inc. ]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/synact-pharma-ab</loc><lastmod>2026-04-18T00:11:06.143Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:06.143Z</news:publication_date><news:title><![CDATA[SynAct Pharma AB]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/remegen-ltd</loc><lastmod>2026-04-18T00:11:02.396Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:11:02.396Z</news:publication_date><news:title><![CDATA[RemeGen Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/hyloris-pharmaceuticals-sa</loc><lastmod>2026-04-18T00:10:58.07Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:58.07Z</news:publication_date><news:title><![CDATA[Hyloris Pharmaceuticals SA]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/natera-inc</loc><lastmod>2026-04-18T00:10:54.007Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:54.007Z</news:publication_date><news:title><![CDATA[Natera, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/keros-therapeutics</loc><lastmod>2026-04-18T00:10:49.95Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:49.95Z</news:publication_date><news:title><![CDATA[Keros Therapeutics]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/pegbio-co-ltd</loc><lastmod>2026-04-18T00:10:45.904Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:45.904Z</news:publication_date><news:title><![CDATA[PegBio Co Ltd]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tiumbio-co-ltd</loc><lastmod>2026-04-18T00:10:41.866Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:41.866Z</news:publication_date><news:title><![CDATA[TiumBio Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/race-oncology-ltd</loc><lastmod>2026-04-18T00:10:35.874Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:35.874Z</news:publication_date><news:title><![CDATA[Race Oncology Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/next-science-ltd</loc><lastmod>2026-04-18T00:10:31.785Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:31.785Z</news:publication_date><news:title><![CDATA[Next Science Ltd]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/immunome-inc</loc><lastmod>2026-04-18T00:10:27.792Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:27.792Z</news:publication_date><news:title><![CDATA[Immunome Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/intech-biopharm-ltd</loc><lastmod>2026-04-18T00:10:25.93Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:25.93Z</news:publication_date><news:title><![CDATA[Intech Biopharm Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nibec-co-ltd</loc><lastmod>2026-04-18T00:10:21.683Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:21.683Z</news:publication_date><news:title><![CDATA[NIBEC Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tr-biofab-co-ltd</loc><lastmod>2026-04-18T00:10:17.758Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:17.758Z</news:publication_date><news:title><![CDATA[T&R Biofab Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/dermapharm-ag</loc><lastmod>2026-04-18T00:10:13.999Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:13.999Z</news:publication_date><news:title><![CDATA[Dermapharm AG]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/rapid-micro-biosystems-inc</loc><lastmod>2026-04-18T00:10:09.727Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:09.727Z</news:publication_date><news:title><![CDATA[Rapid Micro Biosystems Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/mic-ellen-associates-inc</loc><lastmod>2026-04-18T00:10:05.977Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:05.977Z</news:publication_date><news:title><![CDATA[Mic-Ellen Associates Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/xilio-therapeutics-inc</loc><lastmod>2026-04-18T00:10:01.715Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:10:01.715Z</news:publication_date><news:title><![CDATA[Xilio Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/relay-therapeutics-inc</loc><lastmod>2026-04-18T00:09:55.82Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:55.82Z</news:publication_date><news:title><![CDATA[Relay Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/university-of-leipzig</loc><lastmod>2026-04-18T00:09:53.543Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:53.543Z</news:publication_date><news:title><![CDATA[University of Leipzig]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/pharmaron-beijing-ltd-co</loc><lastmod>2026-04-18T00:09:49.383Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:49.383Z</news:publication_date><news:title><![CDATA[Pharmaron Beijing Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/quickcool-ab</loc><lastmod>2026-04-18T00:09:45.512Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:45.512Z</news:publication_date><news:title><![CDATA[QuickCool AB]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/technical-university-of-munich</loc><lastmod>2026-04-18T00:09:41.401Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:41.401Z</news:publication_date><news:title><![CDATA[Technical University of Munich]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/johannes-gutenberg-university</loc><lastmod>2026-04-18T00:09:37.434Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:37.434Z</news:publication_date><news:title><![CDATA[Johannes Gutenberg University]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/mabpharm-limited</loc><lastmod>2026-04-18T00:09:33.323Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:33.323Z</news:publication_date><news:title><![CDATA[Mabpharm Limited]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/lotus-pharmaceutical-co-ltd</loc><lastmod>2026-04-18T00:09:29.237Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:29.237Z</news:publication_date><news:title><![CDATA[Lotus Pharmaceutical Co. Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/novmetapharma-co-ltd</loc><lastmod>2026-04-18T00:09:25.191Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:25.191Z</news:publication_date><news:title><![CDATA[NovMetaPharma Co Ltd]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/biomea-fusion-inc</loc><lastmod>2026-04-18T00:09:21.176Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:21.176Z</news:publication_date><news:title><![CDATA[Biomea Fusion, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/disc-medicine-inc</loc><lastmod>2026-04-18T00:09:16.263Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:16.263Z</news:publication_date><news:title><![CDATA[Disc Medicine, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/sight-sciences-inc</loc><lastmod>2026-04-18T00:09:10.239Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:10.239Z</news:publication_date><news:title><![CDATA[Sight Sciences, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/opus-genetics-inc</loc><lastmod>2026-04-18T00:09:04.285Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:09:04.285Z</news:publication_date><news:title><![CDATA[Opus Genetics, Inc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/prelude-therapeutics-incorporated</loc><lastmod>2026-04-18T00:08:58.05Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:58.05Z</news:publication_date><news:title><![CDATA[Prelude Therapeutics Incorporated]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/genenta-science-spa</loc><lastmod>2026-04-18T00:08:52.305Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:52.305Z</news:publication_date><news:title><![CDATA[Genenta Science SpA]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/olix-pharmaceuticals-inc</loc><lastmod>2026-04-18T00:08:46.02Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:46.02Z</news:publication_date><news:title><![CDATA[OliX Pharmaceuticals, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/gossamer-bio-inc</loc><lastmod>2026-04-18T00:08:40.28Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:40.28Z</news:publication_date><news:title><![CDATA[Gossamer Bio, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/intron-biotechnology-inc</loc><lastmod>2026-04-18T00:08:34.142Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:34.142Z</news:publication_date><news:title><![CDATA[iNtRON Biotechnology, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tango-therapeutics-inc</loc><lastmod>2026-04-18T00:08:27.861Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:27.861Z</news:publication_date><news:title><![CDATA[Tango Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/beam-therapeutics-inc</loc><lastmod>2026-04-18T00:08:22.126Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:22.126Z</news:publication_date><news:title><![CDATA[Beam Therapeutics Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/camp4-therapeutics-corp</loc><lastmod>2026-04-18T00:08:15.837Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:15.837Z</news:publication_date><news:title><![CDATA[CAMP4 Therapeutics Corp.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/essex-bio-technology-limited</loc><lastmod>2026-04-18T00:08:10.01Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:10.01Z</news:publication_date><news:title><![CDATA[Essex Bio-Technology Limited]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/kodiak-sciences-inc</loc><lastmod>2026-04-18T00:08:03.881Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:08:03.881Z</news:publication_date><news:title><![CDATA[Kodiak Sciences Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/tonghua-dongbao-pharmaceutical-co-ltd</loc><lastmod>2026-04-18T00:07:57.759Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:57.759Z</news:publication_date><news:title><![CDATA[Tonghua Dongbao Pharmaceutical Co Ltd]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/panacea-biotec-ltd</loc><lastmod>2026-04-18T00:07:51.609Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:51.609Z</news:publication_date><news:title><![CDATA[Panacea Biotec Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/hanx-biopharmaceuticals-inc</loc><lastmod>2026-04-18T00:07:45.697Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:45.697Z</news:publication_date><news:title><![CDATA[HanX Biopharmaceuticals, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/wockhardt-limited</loc><lastmod>2026-04-18T00:07:39.721Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:39.721Z</news:publication_date><news:title><![CDATA[Wockhardt Limited]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/hls-therapeutics-inc</loc><lastmod>2026-04-18T00:07:33.536Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:33.536Z</news:publication_date><news:title><![CDATA[HLS Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/quince-therapeutics-inc</loc><lastmod>2026-04-18T00:07:27.626Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:27.626Z</news:publication_date><news:title><![CDATA[Quince Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/verrica-pharmaceuticals-inc</loc><lastmod>2026-04-18T00:07:21.481Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:21.481Z</news:publication_date><news:title><![CDATA[Verrica Pharmaceuticals, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/osang-healthcare-co-ltd</loc><lastmod>2026-04-18T00:07:15.541Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:15.541Z</news:publication_date><news:title><![CDATA[OSANG Healthcare Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/promis-neurosciences-inc</loc><lastmod>2026-04-18T00:07:09.641Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:09.641Z</news:publication_date><news:title><![CDATA[ProMIS Neurosciences, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/replimune-group-inc</loc><lastmod>2026-04-18T00:07:03.729Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:07:03.729Z</news:publication_date><news:title><![CDATA[Replimune Group Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/shandong-weigao-group-medical-polymer-company-limited</loc><lastmod>2026-04-18T00:06:57.62Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:57.62Z</news:publication_date><news:title><![CDATA[Shandong Weigao Group Medical Polymer Company Limited]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/sera-prognostics-inc</loc><lastmod>2026-04-18T00:06:51.492Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:51.492Z</news:publication_date><news:title><![CDATA[Sera Prognostics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/helius-medical-technologies-inc</loc><lastmod>2026-04-18T00:06:45.562Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:45.562Z</news:publication_date><news:title><![CDATA[Helius Medical Technologies, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/mereo-biopharma-group-plc</loc><lastmod>2026-04-18T00:06:33.445Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:33.445Z</news:publication_date><news:title><![CDATA[Mereo BioPharma Group plc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/sab-bio</loc><lastmod>2026-04-18T00:06:27.475Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:27.475Z</news:publication_date><news:title><![CDATA[SAB BIO]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/quanterix-corporation</loc><lastmod>2026-04-18T00:06:21.206Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:21.206Z</news:publication_date><news:title><![CDATA[Quanterix Corporation]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/harvard-bioscience-inc</loc><lastmod>2026-04-18T00:06:15.522Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:15.522Z</news:publication_date><news:title><![CDATA[Harvard Bioscience, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/sirnaomics-inc</loc><lastmod>2026-04-18T00:06:09.219Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:09.219Z</news:publication_date><news:title><![CDATA[Sirnaomics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/healios-kk</loc><lastmod>2026-04-18T00:06:03.337Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:06:03.337Z</news:publication_date><news:title><![CDATA[Healios K.K.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/guardant-health-inc</loc><lastmod>2026-04-18T00:05:57.132Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:57.132Z</news:publication_date><news:title><![CDATA[Guardant Health, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/hutchmed-china-limited</loc><lastmod>2026-04-18T00:05:51.273Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:51.273Z</news:publication_date><news:title><![CDATA[HUTCHMED (China) Limited]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/ovid-therapeutics-inc</loc><lastmod>2026-04-18T00:05:45.135Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:45.135Z</news:publication_date><news:title><![CDATA[Ovid Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/nexstim-plc</loc><lastmod>2026-04-18T00:05:39.221Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:39.221Z</news:publication_date><news:title><![CDATA[Nexstim Plc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/kazia-therapeutics-limited</loc><lastmod>2026-04-18T00:05:33.156Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:33.156Z</news:publication_date><news:title><![CDATA[Kazia Therapeutics Limited]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/handok</loc><lastmod>2026-04-18T00:05:27.046Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:27.046Z</news:publication_date><news:title><![CDATA[Handok]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/neuronetics-inc</loc><lastmod>2026-04-18T00:05:21.318Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:21.318Z</news:publication_date><news:title><![CDATA[Neuronetics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/rezolute-inc</loc><lastmod>2026-04-18T00:05:12.096Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:12.096Z</news:publication_date><news:title><![CDATA[Rezolute, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/sutro-biopharma-inc</loc><lastmod>2026-04-18T00:05:00.031Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:05:00.031Z</news:publication_date><news:title><![CDATA[Sutro Biopharma, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/inspire-medical-systems-inc</loc><lastmod>2026-04-18T00:04:35.983Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:04:35.983Z</news:publication_date><news:title><![CDATA[Inspire Medical Systems, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/cellectis-sa</loc><lastmod>2026-04-18T00:04:24.04Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:04:24.04Z</news:publication_date><news:title><![CDATA[Cellectis SA]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/whitehawk-therapeutics-inc</loc><lastmod>2026-04-18T00:04:12.002Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:04:12.002Z</news:publication_date><news:title><![CDATA[Whitehawk Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/perspective-therapeutics-inc</loc><lastmod>2026-04-18T00:03:59.826Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:03:59.826Z</news:publication_date><news:title><![CDATA[Perspective Therapeutics, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/fresenius-se-co-kgaa</loc><lastmod>2026-04-18T00:03:47.756Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:03:47.756Z</news:publication_date><news:title><![CDATA[Fresenius SE & Co. KGaA]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/transgene-sa</loc><lastmod>2026-04-18T00:03:23.82Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:03:23.82Z</news:publication_date><news:title><![CDATA[Transgene S.A.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/compugen-ltd</loc><lastmod>2026-04-18T00:03:11.808Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:03:11.808Z</news:publication_date><news:title><![CDATA[Compugen Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/helix-biopharma-corp</loc><lastmod>2026-04-18T00:02:59.724Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:02:59.724Z</news:publication_date><news:title><![CDATA[Helix BioPharma Corp]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/oncolytics-biotech-inc</loc><lastmod>2026-04-18T00:02:47.684Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:02:47.684Z</news:publication_date><news:title><![CDATA[Oncolytics Biotech, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/helixmith-co-ltd</loc><lastmod>2026-04-18T00:02:35.752Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:02:35.752Z</news:publication_date><news:title><![CDATA[Helixmith Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/taigen-biotechnology-co-ltd</loc><lastmod>2026-04-18T00:02:23.457Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:02:23.457Z</news:publication_date><news:title><![CDATA[TaiGen Biotechnology Co., Ltd.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/inovio-pharmaceuticals-inc</loc><lastmod>2026-04-18T00:02:11.881Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:02:11.881Z</news:publication_date><news:title><![CDATA[Inovio Pharmaceuticals, Inc.]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/silence-therapeutics-plc</loc><lastmod>2026-04-18T00:01:59.564Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:01:59.564Z</news:publication_date><news:title><![CDATA[Silence Therapeutics plc]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/orexo-ab</loc><lastmod>2026-04-18T00:01:47.501Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:01:47.501Z</news:publication_date><news:title><![CDATA[Orexo AB]]></news:title></news:news></url><url><loc>https://insights.citeline.com/companies/insmed-incorporated</loc><lastmod>2026-04-18T00:01:35.726Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><news:news><news:publication><news:name>Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-18T00:01:35.726Z</news:publication_date><news:title><![CDATA[Insmed Incorporated]]></news:title></news:news></url></urlset>